Myocardial anomalies detected in long-distance runners after they cross the finish line should not be interpreted as signs of possible heart damage. Using cardiac MR, Canadian investigators have found evidence that these abnormalities are only temporary.
Myocardial anomalies detected in long-distance runners after they cross the finish line should not be interpreted as signs of possible heart damage. Using cardiac MR, Canadian investigators have found evidence that these abnormalities are only temporary.
"By using CMR, we were able to definitively show that these fluctuations do not result in any true damage of the heart. The right ventricular dysfunction is transient, recovering one week following the race," said study investigator Dr. Davinder S. Jassal, an assistant professor of cardiology, radiology, and physiology at St. Boniface General Hospital Research Center in Winnipeg, MB.
Jassal and colleagues assessed the cardiac health of 14 nonprofessional athletes who ran the 2008 Manitoba Marathon hosted in Winnipeg. All subjects underwent a comprehensive health screening before the marathon, including a blood test of cardiac biomarkers to evaluate myocardial health. They also underwent additional blood tests, echocardiograms, and CMR after the race.
Results from the echocardiograms and CMR scans performed immediately after the marathon showed diastolic filling irregularities on both sides of the heart and a decrease from 64% to 43% in the pumping function of the right ventricle. Cardiac biomarkers also showed postmarathon abnormalities.
The investigators found no evidence, however, of permanent myocardial injury on follow-up CMR. They presented results in May at the 2009 International Conference of the American Thoracic Society in San Diego.
More nonprofessional athletes are running marathons for pleasure and the promise of improved cardiovascular health. But until this study, clinical experience suggested extreme long-distance running could be a killer in more than one sense.
"Although previous studies of marathon runners have demonstrated biochemical evidence of cardiac injury and have correlated these findings with echocardiographic evidence of cardiac dysfunction, this was the first time CMR has been used to further evaluate and understand the effects of marathon running on the heart," Jassal said.
Jassal's investigative group plans additional studies to determine whether these abnormalities may result in permanent damage in runners who participate in more than one marathon during a 12-month period.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).